|
Variables (n= 150)
|
Mean (SD)
|
Median (Q1 to Q3)
|
|---|
|
Age
|
52.1 (10.0)
|
52.9 (45.6 to 60.0)
|
|
Duration since onset of symptom (months)
|
48.7 (23.2)
|
46.0 (33.0 to 60.0)
|
|
Duration since first clinic visit (months)
|
37.5 (18.3)
|
35.7 (23.7 to 50.9)
|
|
Function (0 to 3)
|
0.6 (0.5)
|
0.5 (0.2 to 0.9)
|
|
Pain (0 to 10)
|
3.6 (2.5)
|
3.0 (1.5 to 5.5)
|
|
Pt global estimate (0 to 10)
|
3.0 (2.4)
|
2.5 (1.0 to 5.0)
|
|
Fatigue (0 to 10)
|
4.6 (2.9)
|
5.0 (2.0 to 7.0)
|
|
PtGA (0 to 10)
|
3.6 (2.6)
|
3.0 (1.5 to 5.5)
|
| |
n
|
%
|
|
Female
|
108
|
72.0
|
- Pt global estimate, patient global estimate on health impact; PtGA, patient global assessment of disease activity; Q1, first quartile; Q3, third quartile
